France-based Ipsen SA has reported a rise in sales for the global specialty care market and a decline in revenue from primary care. Overall first quarter sales were €362 million, up by 3.4%, of which specialty care sales represented nearly 80%. ---Subscribe to MedNous to access this article--- Company News
